Cargando…
Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus
The structural repertoire of bioactive naphthacene quinones is expanded by engineering Streptomyces albus to express the lysolipin minimal polyketide synthase II (PKS II) genes from Streptomyces tendae Tü 4042 (llpD-F) with the corresponding cyclase genes llpCI-CIII. Fermentation of the recombinant...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164072/ https://www.ncbi.nlm.nih.gov/pubmed/29958422 http://dx.doi.org/10.3390/antibiotics7030053 |
_version_ | 1783359513039994880 |
---|---|
author | Hofeditz, Torben Unsin, Claudia Eva-Maria Wiese, Jutta Imhoff, Johannes F. Wohlleben, Wolfgang Grond, Stephanie Weber, Tilmann |
author_facet | Hofeditz, Torben Unsin, Claudia Eva-Maria Wiese, Jutta Imhoff, Johannes F. Wohlleben, Wolfgang Grond, Stephanie Weber, Tilmann |
author_sort | Hofeditz, Torben |
collection | PubMed |
description | The structural repertoire of bioactive naphthacene quinones is expanded by engineering Streptomyces albus to express the lysolipin minimal polyketide synthase II (PKS II) genes from Streptomyces tendae Tü 4042 (llpD-F) with the corresponding cyclase genes llpCI-CIII. Fermentation of the recombinant strain revealed the two new polyaromatic tridecaketides lysoquinone-TH1 (7, identified) and TH2 (8, postulated structure) as engineered congeners of the dodecaketide lysolipin (1). The chemical structure of 7, a benzo[a]naphthacene-8,13-dione, was elucidated by NMR and HR-MS and confirmed by feeding experiments with [1,2-(13)C(2)]-labeled acetate. Lysoquinone-TH1 (7) is a pentangular polyphenol and one example of such rare extended polyaromatic systems of the benz[a]napthacene quinone type produced by the expression of a minimal PKS II in combination with cyclases in an artificial system. While the natural product lysolipin (1) has antimicrobial activity in nM-range, lysoquinone-TH1 (7) showed only minor potency as inhibitor of Gram-positive microorganisms. The bioactivity profiling of lysoquinone-TH1 (7) revealed inhibitory activity towards phosphodiesterase 4 (PDE4), an important target for the treatment in human health like asthma or chronic obstructive pulmonary disease (COPD). These results underline the availability of pentangular polyphenolic structural skeletons from biosynthetic engineering in the search of new chemical entities in drug discovery. |
format | Online Article Text |
id | pubmed-6164072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61640722018-10-12 Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus Hofeditz, Torben Unsin, Claudia Eva-Maria Wiese, Jutta Imhoff, Johannes F. Wohlleben, Wolfgang Grond, Stephanie Weber, Tilmann Antibiotics (Basel) Article The structural repertoire of bioactive naphthacene quinones is expanded by engineering Streptomyces albus to express the lysolipin minimal polyketide synthase II (PKS II) genes from Streptomyces tendae Tü 4042 (llpD-F) with the corresponding cyclase genes llpCI-CIII. Fermentation of the recombinant strain revealed the two new polyaromatic tridecaketides lysoquinone-TH1 (7, identified) and TH2 (8, postulated structure) as engineered congeners of the dodecaketide lysolipin (1). The chemical structure of 7, a benzo[a]naphthacene-8,13-dione, was elucidated by NMR and HR-MS and confirmed by feeding experiments with [1,2-(13)C(2)]-labeled acetate. Lysoquinone-TH1 (7) is a pentangular polyphenol and one example of such rare extended polyaromatic systems of the benz[a]napthacene quinone type produced by the expression of a minimal PKS II in combination with cyclases in an artificial system. While the natural product lysolipin (1) has antimicrobial activity in nM-range, lysoquinone-TH1 (7) showed only minor potency as inhibitor of Gram-positive microorganisms. The bioactivity profiling of lysoquinone-TH1 (7) revealed inhibitory activity towards phosphodiesterase 4 (PDE4), an important target for the treatment in human health like asthma or chronic obstructive pulmonary disease (COPD). These results underline the availability of pentangular polyphenolic structural skeletons from biosynthetic engineering in the search of new chemical entities in drug discovery. MDPI 2018-06-28 /pmc/articles/PMC6164072/ /pubmed/29958422 http://dx.doi.org/10.3390/antibiotics7030053 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hofeditz, Torben Unsin, Claudia Eva-Maria Wiese, Jutta Imhoff, Johannes F. Wohlleben, Wolfgang Grond, Stephanie Weber, Tilmann Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title | Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title_full | Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title_fullStr | Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title_full_unstemmed | Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title_short | Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in Streptomyces albus |
title_sort | lysoquinone-th1, a new polyphenolic tridecaketide produced by expressing the lysolipin minimal pks ii in streptomyces albus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164072/ https://www.ncbi.nlm.nih.gov/pubmed/29958422 http://dx.doi.org/10.3390/antibiotics7030053 |
work_keys_str_mv | AT hofeditztorben lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT unsinclaudiaevamaria lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT wiesejutta lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT imhoffjohannesf lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT wohllebenwolfgang lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT grondstephanie lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus AT webertilmann lysoquinoneth1anewpolyphenolictridecaketideproducedbyexpressingthelysolipinminimalpksiiinstreptomycesalbus |